FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2980968105> ?p ?o ?g. }

• W2980968105 endingPage "126710" @default.
• W2980968105 startingPage "126710" @default.
• W2980968105 abstract "We report herein the synthesis of a newly described anti-cancer agent, NRPa-308. This compound antagonizes Neuropilin-1, a multi-partners transmembrane receptor overexpressed in numerous tumors, and thereby validated as promising target in oncology. The preparation of NRPa-308 proved challenging because of the orthogonality of the amide and sulphonamide bonds formation. Nevertheless, we succeeded a gram scale synthesis, according to an expeditious three steps route, without intermediate purification. This latter point is of utmost interest in reducing the ecologic impact and production costs in the perspective of further scale-up processes. The purity of NRPa-308 has been attested by means of conventional structural analyses and its crystallisation allowed a structural assessment by X-Ray diffraction. We also reported the remarkable chemical stability of this molecule in acidic, neutral and basic aqueous media. Eventually, we observed for the first time the accumulation of NRPa-308 in two types of human breast cancer cells MDA-MB231 and BT549." @default.
• W2980968105 created "2019-10-25" @default.
• W2980968105 creator A5003446201 @default.
• W2980968105 creator A5011388889 @default.
• W2980968105 creator A5013876454 @default.
• W2980968105 creator A5035512825 @default.
• W2980968105 creator A5036368816 @default.
• W2980968105 creator A5041784822 @default.
• W2980968105 creator A5052078344 @default.
• W2980968105 creator A5054373904 @default.
• W2980968105 creator A5055177972 @default.
• W2980968105 creator A5064856085 @default.
• W2980968105 creator A5065024340 @default.
• W2980968105 creator A5084704633 @default.
• W2980968105 creator A5087525957 @default.
• W2980968105 creator A5090083053 @default.
• W2980968105 date "2019-12-01" @default.
• W2980968105 modified "2023-10-14" @default.
• W2980968105 title "Synthesis, 3D-structure and stability analyses of NRPa-308, a new promising anti-cancer agent" @default.
• W2980968105 cites W1640172633 @default.
• W2980968105 cites W1863618180 @default.
• W2980968105 cites W1921756464 @default.
• W2980968105 cites W1923747308 @default.
• W2980968105 cites W1969477095 @default.
• W2980968105 cites W1989658253 @default.
• W2980968105 cites W1994573674 @default.
• W2980968105 cites W2000292756 @default.
• W2980968105 cites W2003147884 @default.
• W2980968105 cites W2009616314 @default.
• W2980968105 cites W2022728604 @default.
• W2980968105 cites W2035304807 @default.
• W2980968105 cites W2059735139 @default.
• W2980968105 cites W2063334178 @default.
• W2980968105 cites W2065416921 @default.
• W2980968105 cites W2080890220 @default.
• W2980968105 cites W2084587800 @default.
• W2980968105 cites W2092911713 @default.
• W2980968105 cites W2101017584 @default.
• W2980968105 cites W2122813920 @default.
• W2980968105 cites W2131350133 @default.
• W2980968105 cites W2131404391 @default.
• W2980968105 cites W2137945824 @default.
• W2980968105 cites W2163326536 @default.
• W2980968105 cites W2174608683 @default.
• W2980968105 cites W2328005464 @default.
• W2980968105 cites W2483668819 @default.
• W2980968105 cites W2535686641 @default.
• W2980968105 cites W2557794574 @default.
• W2980968105 cites W2594006777 @default.
• W2980968105 cites W2761867567 @default.
• W2980968105 cites W2766241265 @default.
• W2980968105 cites W2772621511 @default.
• W2980968105 cites W2801452578 @default.
• W2980968105 cites W2886038660 @default.
• W2980968105 cites W2940707075 @default.
• W2980968105 cites W2944259204 @default.
• W2980968105 cites W299819462 @default.
• W2980968105 doi "https://doi.org/10.1016/j.bmcl.2019.126710" @default.
• W2980968105 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31699610" @default.
• W2980968105 hasPublicationYear "2019" @default.
• W2980968105 type Work @default.
• W2980968105 sameAs 2980968105 @default.
• W2980968105 citedByCount "7" @default.
• W2980968105 countsByYear W29809681052020 @default.
• W2980968105 countsByYear W29809681052021 @default.
• W2980968105 countsByYear W29809681052022 @default.
• W2980968105 countsByYear W29809681052023 @default.
• W2980968105 crossrefType "journal-article" @default.
• W2980968105 hasAuthorship W2980968105A5003446201 @default.
• W2980968105 hasAuthorship W2980968105A5011388889 @default.
• W2980968105 hasAuthorship W2980968105A5013876454 @default.
• W2980968105 hasAuthorship W2980968105A5035512825 @default.
• W2980968105 hasAuthorship W2980968105A5036368816 @default.
• W2980968105 hasAuthorship W2980968105A5041784822 @default.
• W2980968105 hasAuthorship W2980968105A5052078344 @default.
• W2980968105 hasAuthorship W2980968105A5054373904 @default.
• W2980968105 hasAuthorship W2980968105A5055177972 @default.
• W2980968105 hasAuthorship W2980968105A5064856085 @default.
• W2980968105 hasAuthorship W2980968105A5065024340 @default.
• W2980968105 hasAuthorship W2980968105A5084704633 @default.
• W2980968105 hasAuthorship W2980968105A5087525957 @default.
• W2980968105 hasAuthorship W2980968105A5090083053 @default.
• W2980968105 hasBestOaLocation W29809681051 @default.
• W2980968105 hasConcept C121608353 @default.
• W2980968105 hasConcept C126322002 @default.
• W2980968105 hasConcept C170493617 @default.
• W2980968105 hasConcept C171250308 @default.
• W2980968105 hasConcept C178790620 @default.
• W2980968105 hasConcept C185592680 @default.
• W2980968105 hasConcept C192562407 @default.
• W2980968105 hasConcept C21951064 @default.
• W2980968105 hasConcept C24530287 @default.
• W2980968105 hasConcept C2778439535 @default.
• W2980968105 hasConcept C32909587 @default.
• W2980968105 hasConcept C55493867 @default.
• W2980968105 hasConcept C70721500 @default.
• W2980968105 hasConcept C71240020 @default.
• W2980968105 hasConcept C71924100 @default.

• next